Skin Tone Measurement Method Investigation for Pulse Oximetry
1 other identifier
observational
12
1 country
1
Brief Summary
The primary objective is to gather missing information in order to form a well-founded recommendation on which is the preferred skin pigmentation measurement (PPM) methods in the context of pulse-oximetry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2022
CompletedFirst Posted
Study publicly available on registry
December 20, 2022
CompletedStudy Start
First participant enrolled
February 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 11, 2023
CompletedApril 12, 2023
April 1, 2023
2 months
December 12, 2022
April 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preferred skin PMM in the context of pulse-oximetry.
The primary objective is to complement a previous skin pigmentation study executed by Philips to gather missing information in order to form a well-founded recommendation on which is the preferred skin PPM in the context of pulse-oximetry.
10 months
Interventions
Objective and subjective skin tone measurements will be performed.
Eligibility Criteria
Healthy volunteers with Von Luschan scores \<18 ('light skin' group) or \> 25 ('dark skin' group.
You may qualify if:
- Adults (18-65 years)
- Fluent in either English or Dutch
- Participants who are willing and able to provide informed consent themselves.
- People with Von Luschan scores \<18 ('light skin' group) or \> 25 ('dark skin' group).
You may not qualify if:
- Skin conditions that could potentially interfere with the measurements:
- piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead
- vascular or pigmentary or renal psoriasis
- epidermal bullosum
- other diseases that affect the skin (tone) of the body
- Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing
- Having been positively tested as infected with COVID-19 in the past 14 days
- Travelled to or from high risk COVID-19 areas in the past 14 days
- Been in contact with a (suspected) COVID-infected person in the past 14 days
- Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures
- Sunbathing during the study duration or substantial sun exposure (due to holidays for example).
- Known allergic reaction to facial make-up
- Usage of tanning sprays/cremes
- Wearing make-up during the study visits (mascara is allowed)
- No testing will be performed in the study. Participants will be asked if they have been positively tested.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
High Tech Campus
Eindhoven, Netherlands
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2022
First Posted
December 20, 2022
Study Start
February 6, 2023
Primary Completion
April 11, 2023
Study Completion
April 11, 2023
Last Updated
April 12, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
The plan is to perform data analysis by Philips Research. Thereafter data will be shared (de-identified) in a seperate publication that can be accessed overall.